Publication: Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis
| dc.contributor.author | EREN, FATİH | |
| dc.contributor.authors | Yilmaz, Yusuf; Eren, Fatih | |
| dc.date.accessioned | 2022-03-12T18:05:15Z | |
| dc.date.available | 2022-03-12T18:05:15Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Background: Although liver biopsy remains the best diagnostic standard for nonalcoholic steatohepatitis (NASH), non-invasive tests are eagerly awaited. In this study, we sought to develop a support vector machine (SVM) algorithm to discriminate with high accuracy between subjects with NASH and controls using a blood-based biomarker panel. Methods: A total of 17 biomarkers were measured by commercially available enzyme-linked immunosorbent assays in 136 serum samples from patients with biopsy-proven NASH (n = 60) and subjects with normal ALT and no evidence of fatty liver on ultrasound (n = 76). The database was randomly divided (1:1 fashion) into a discovery set for classification training and in a validation set of the chosen biomarkers in blinded samples. Multivariate analysis was performed by means of SVM. Results: After the identification of a group of three most discriminative biomarkers (osteoprotegerin, fibroblast growth factor 21, and M30) in the discovery set, the application of SVM to the validation test resulted in a 92.5% sensitivity and 84.1% specificity for distinguishing subjects with NASH from controls. Conclusions: A targeted biomarker profiling combined with a SVM-based pattern identification approach may allow the identification of patients with NASH with clinically relevant accuracy and validity. (C) 2012 Elsevier B.V. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.cca.2012.08.005 | |
| dc.identifier.issn | 0009-8981 | |
| dc.identifier.pubmed | 22985537 | |
| dc.identifier.uri | https://hdl.handle.net/11424/230649 | |
| dc.identifier.wos | WOS:000312685400032 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE BV | |
| dc.relation.ispartof | CLINICA CHIMICA ACTA | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Nonalcoholic steatohepatitis | |
| dc.subject | Support vector machine | |
| dc.subject | Biomarkers | |
| dc.subject | Diagnostic panel | |
| dc.subject | FATTY LIVER-DISEASE | |
| dc.subject | SERUM FGF21 LEVELS | |
| dc.subject | METABOLIC SYNDROME | |
| dc.subject | SIMPLE STEATOSIS | |
| dc.subject | GROWTH-FACTOR | |
| dc.subject | DIAGNOSIS | |
| dc.subject | FIBROSIS | |
| dc.subject | NASH | |
| dc.subject | CYTOKERATIN-18 | |
| dc.title | Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| local.avesis.id | 5a13cbfa-9aee-4f67-ad12-65a41a9abdeb | |
| local.import.package | SS17 | |
| local.indexed.at | WOS | |
| local.indexed.at | SCOPUS | |
| local.indexed.at | PUBMED | |
| local.journal.numberofpages | 4 | |
| oaire.citation.endPage | 157 | |
| oaire.citation.startPage | 154 | |
| oaire.citation.title | CLINICA CHIMICA ACTA | |
| oaire.citation.volume | 414 | |
| relation.isAuthorOfPublication | 4bc77d63-5aa7-4c67-8d60-12778ea963b1 | |
| relation.isAuthorOfPublication.latestForDiscovery | 4bc77d63-5aa7-4c67-8d60-12778ea963b1 |